| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pituitary Neoplasms | 266 | 2024 | 1313 | 25.920 |
Why?
|
| Adenoma | 177 | 2024 | 2148 | 13.220 |
Why?
|
| Sphenoid Bone | 70 | 2024 | 177 | 9.790 |
Why?
|
| Neurosurgical Procedures | 76 | 2021 | 2056 | 8.450 |
Why?
|
| Sella Turcica | 50 | 2024 | 118 | 7.140 |
Why?
|
| Pituitary Gland | 58 | 2023 | 637 | 6.880 |
Why?
|
| Craniopharyngioma | 36 | 2021 | 277 | 6.000 |
Why?
|
| Pituitary ACTH Hypersecretion | 28 | 2023 | 178 | 5.850 |
Why?
|
| Skull Base | 19 | 2018 | 291 | 5.590 |
Why?
|
| Neurosurgery | 41 | 2021 | 670 | 4.720 |
Why?
|
| Endoscopy | 32 | 2022 | 1838 | 4.300 |
Why?
|
| Sphenoid Sinus | 28 | 2017 | 99 | 4.240 |
Why?
|
| Pituitary Diseases | 29 | 2019 | 135 | 3.840 |
Why?
|
| Neuroendoscopy | 9 | 2024 | 98 | 3.610 |
Why?
|
| Acromegaly | 38 | 2021 | 306 | 3.560 |
Why?
|
| ACTH-Secreting Pituitary Adenoma | 13 | 2023 | 63 | 3.440 |
Why?
|
| Central Nervous System Cysts | 11 | 2021 | 56 | 3.270 |
Why?
|
| Nasal Cavity | 15 | 2019 | 304 | 2.770 |
Why?
|
| Prolactinoma | 13 | 2019 | 113 | 2.680 |
Why?
|
| Skull Base Neoplasms | 14 | 2021 | 269 | 2.670 |
Why?
|
| Hypophysectomy | 23 | 2018 | 114 | 2.620 |
Why?
|
| Pituitary Apoplexy | 10 | 2016 | 29 | 2.230 |
Why?
|
| Cushing Syndrome | 23 | 2010 | 241 | 2.190 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 14 | 2016 | 87 | 2.110 |
Why?
|
| Microsurgery | 25 | 2014 | 796 | 2.090 |
Why?
|
| Radiosurgery | 26 | 2011 | 1343 | 1.620 |
Why?
|
| Postoperative Complications | 72 | 2019 | 15697 | 1.550 |
Why?
|
| Human Growth Hormone | 12 | 2016 | 638 | 1.460 |
Why?
|
| Brain Neoplasms | 70 | 2017 | 8986 | 1.420 |
Why?
|
| Intraoperative Complications | 12 | 2024 | 1186 | 1.310 |
Why?
|
| Dopamine Agonists | 8 | 2019 | 352 | 1.230 |
Why?
|
| History, 20th Century | 38 | 2016 | 2773 | 1.160 |
Why?
|
| Arachnoid Cysts | 6 | 2019 | 61 | 1.160 |
Why?
|
| Stereotaxic Techniques | 14 | 2007 | 549 | 1.130 |
Why?
|
| Cysts | 6 | 2021 | 683 | 1.130 |
Why?
|
| Hydrocortisone | 16 | 2023 | 1803 | 1.120 |
Why?
|
| Hypopituitarism | 20 | 2018 | 248 | 1.110 |
Why?
|
| Humans | 538 | 2024 | 760621 | 1.070 |
Why?
|
| Neuronavigation | 3 | 2016 | 164 | 1.060 |
Why?
|
| Preoperative Care | 12 | 2020 | 2256 | 1.030 |
Why?
|
| Surgery, Computer-Assisted | 6 | 2016 | 1008 | 1.010 |
Why?
|
| Ki-67 Antigen | 10 | 2016 | 631 | 1.000 |
Why?
|
| Headache | 5 | 2017 | 1249 | 0.960 |
Why?
|
| Endocrine Surgical Procedures | 4 | 2015 | 32 | 0.930 |
Why?
|
| Chordoma | 11 | 2017 | 346 | 0.920 |
Why?
|
| Magnetic Resonance Imaging | 71 | 2023 | 36290 | 0.910 |
Why?
|
| Adrenocorticotropic Hormone | 23 | 2021 | 618 | 0.900 |
Why?
|
| Glioma | 30 | 2013 | 3420 | 0.900 |
Why?
|
| Craniotomy | 19 | 2010 | 741 | 0.900 |
Why?
|
| Astrocytoma | 24 | 2005 | 775 | 0.870 |
Why?
|
| History, 19th Century | 20 | 2015 | 720 | 0.870 |
Why?
|
| Adult | 254 | 2024 | 219994 | 0.860 |
Why?
|
| Cerebrospinal Fluid Shunts | 14 | 2016 | 195 | 0.840 |
Why?
|
| Retrospective Studies | 91 | 2024 | 80372 | 0.830 |
Why?
|
| Prolactin | 34 | 2016 | 621 | 0.820 |
Why?
|
| Neoplasm Recurrence, Local | 38 | 2024 | 9276 | 0.820 |
Why?
|
| Male | 286 | 2024 | 359744 | 0.820 |
Why?
|
| Triiodothyronine | 4 | 2017 | 493 | 0.810 |
Why?
|
| Neoplasm Invasiveness | 19 | 2016 | 3618 | 0.810 |
Why?
|
| Hyperprolactinemia | 5 | 2016 | 123 | 0.810 |
Why?
|
| Natural Orifice Endoscopic Surgery | 3 | 2019 | 119 | 0.810 |
Why?
|
| Female | 296 | 2024 | 391270 | 0.810 |
Why?
|
| Middle Aged | 215 | 2024 | 220352 | 0.780 |
Why?
|
| Treatment Outcome | 84 | 2024 | 65017 | 0.770 |
Why?
|
| Skull Neoplasms | 5 | 2013 | 173 | 0.750 |
Why?
|
| Dermoid Cyst | 3 | 2016 | 92 | 0.720 |
Why?
|
| Inappropriate ADH Syndrome | 4 | 2018 | 60 | 0.710 |
Why?
|
| Cavernous Sinus | 6 | 2016 | 123 | 0.690 |
Why?
|
| Diabetes Insipidus | 10 | 2015 | 144 | 0.680 |
Why?
|
| Adenoma, Oxyphilic | 2 | 2018 | 148 | 0.680 |
Why?
|
| Postoperative Care | 10 | 2020 | 1479 | 0.660 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 4 | 2016 | 49 | 0.650 |
Why?
|
| Encephalocele | 2 | 2015 | 135 | 0.640 |
Why?
|
| Brain Abscess | 2 | 2018 | 120 | 0.630 |
Why?
|
| Intraoperative Care | 3 | 2020 | 768 | 0.610 |
Why?
|
| Dura Mater | 5 | 2012 | 290 | 0.610 |
Why?
|
| Meningeal Neoplasms | 9 | 2021 | 1249 | 0.600 |
Why?
|
| Aged | 152 | 2024 | 169152 | 0.590 |
Why?
|
| Psychosurgery | 4 | 2015 | 86 | 0.590 |
Why?
|
| Abdominal Fat | 1 | 2019 | 223 | 0.570 |
Why?
|
| Hyponatremia | 4 | 2018 | 279 | 0.570 |
Why?
|
| Follow-Up Studies | 62 | 2022 | 39261 | 0.560 |
Why?
|
| Gonadotrophs | 1 | 2016 | 19 | 0.560 |
Why?
|
| Adolescent | 123 | 2024 | 87810 | 0.550 |
Why?
|
| Drinking | 1 | 2018 | 199 | 0.550 |
Why?
|
| Pituitary Function Tests | 7 | 2015 | 24 | 0.550 |
Why?
|
| Vision Disorders | 16 | 2019 | 1084 | 0.520 |
Why?
|
| American Civil War | 1 | 2015 | 8 | 0.520 |
Why?
|
| Meningocele | 1 | 2015 | 46 | 0.520 |
Why?
|
| Drainage | 2 | 2018 | 1161 | 0.490 |
Why?
|
| Meningitis, Pneumococcal | 1 | 2015 | 43 | 0.490 |
Why?
|
| Hemostasis, Surgical | 3 | 2002 | 129 | 0.480 |
Why?
|
| Meningioma | 12 | 2010 | 1221 | 0.480 |
Why?
|
| Diskectomy | 2 | 2015 | 209 | 0.480 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2016 | 4048 | 0.470 |
Why?
|
| Meningoencephalitis | 1 | 2015 | 83 | 0.470 |
Why?
|
| Health Priorities | 1 | 2017 | 374 | 0.470 |
Why?
|
| Monitoring, Intraoperative | 4 | 2016 | 942 | 0.470 |
Why?
|
| Reoperation | 14 | 2017 | 4291 | 0.470 |
Why?
|
| Baseball | 1 | 2015 | 95 | 0.460 |
Why?
|
| Surgical Wound Infection | 5 | 2019 | 1527 | 0.460 |
Why?
|
| Head Protective Devices | 1 | 2015 | 118 | 0.460 |
Why?
|
| Liability, Legal | 1 | 2015 | 210 | 0.460 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2008 | 632 | 0.460 |
Why?
|
| Thyrotropin | 10 | 2016 | 832 | 0.450 |
Why?
|
| Epistaxis | 1 | 2014 | 111 | 0.450 |
Why?
|
| Subarachnoid Hemorrhage | 5 | 2016 | 1032 | 0.450 |
Why?
|
| Hormone Replacement Therapy | 3 | 2016 | 755 | 0.440 |
Why?
|
| Health Care Sector | 1 | 2015 | 196 | 0.440 |
Why?
|
| Remission Induction | 15 | 2021 | 2392 | 0.430 |
Why?
|
| Patient Readmission | 3 | 2018 | 3323 | 0.430 |
Why?
|
| Thyroid Diseases | 1 | 2016 | 386 | 0.420 |
Why?
|
| Checklist | 4 | 2016 | 827 | 0.420 |
Why?
|
| Adipose Tissue | 2 | 2016 | 3301 | 0.420 |
Why?
|
| Nose | 7 | 2021 | 519 | 0.420 |
Why?
|
| Societies, Medical | 6 | 2017 | 3905 | 0.410 |
Why?
|
| Carotid Artery, Internal | 2 | 2014 | 438 | 0.400 |
Why?
|
| Brain Injuries | 5 | 2015 | 2044 | 0.390 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 2011 | 255 | 0.390 |
Why?
|
| Postoperative Period | 10 | 2022 | 1818 | 0.390 |
Why?
|
| Methionine | 1 | 2014 | 569 | 0.380 |
Why?
|
| Growth Hormone | 20 | 2004 | 568 | 0.380 |
Why?
|
| Malpractice | 2 | 2015 | 556 | 0.380 |
Why?
|
| Octreotide | 2 | 2005 | 153 | 0.370 |
Why?
|
| Laser Therapy | 4 | 2011 | 1089 | 0.370 |
Why?
|
| Military Medicine | 2 | 2010 | 186 | 0.370 |
Why?
|
| Specialties, Surgical | 1 | 2015 | 388 | 0.360 |
Why?
|
| Lasers, Gas | 1 | 2011 | 94 | 0.360 |
Why?
|
| Indocyanine Green | 1 | 2012 | 236 | 0.350 |
Why?
|
| Psychophysiology | 1 | 2010 | 136 | 0.350 |
Why?
|
| Hospitals, University | 1 | 2011 | 568 | 0.340 |
Why?
|
| Nelson Syndrome | 2 | 2007 | 20 | 0.330 |
Why?
|
| Streptococcus pneumoniae | 1 | 2015 | 732 | 0.330 |
Why?
|
| Glioblastoma | 11 | 2011 | 3484 | 0.330 |
Why?
|
| Neoplasm, Residual | 6 | 2016 | 1007 | 0.330 |
Why?
|
| Intracranial Aneurysm | 7 | 2016 | 1276 | 0.330 |
Why?
|
| Child | 77 | 2021 | 79806 | 0.330 |
Why?
|
| Wounds and Injuries | 2 | 2015 | 2477 | 0.320 |
Why?
|
| Electrocoagulation | 3 | 2000 | 152 | 0.320 |
Why?
|
| Paraneoplastic Endocrine Syndromes | 4 | 1996 | 29 | 0.320 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2013 | 1928 | 0.320 |
Why?
|
| Young Adult | 23 | 2024 | 58741 | 0.310 |
Why?
|
| Diagnosis, Differential | 24 | 2017 | 12965 | 0.310 |
Why?
|
| Case Management | 1 | 2010 | 272 | 0.310 |
Why?
|
| Aged, 80 and over | 36 | 2024 | 58995 | 0.310 |
Why?
|
| Surgical Flaps | 2 | 2016 | 1669 | 0.300 |
Why?
|
| Ergolines | 3 | 2005 | 57 | 0.300 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 2116 | 0.290 |
Why?
|
| Music | 1 | 2010 | 245 | 0.290 |
Why?
|
| Carcinoma | 5 | 2011 | 2331 | 0.280 |
Why?
|
| Karnofsky Performance Status | 3 | 2010 | 165 | 0.280 |
Why?
|
| Prognosis | 32 | 2021 | 29658 | 0.280 |
Why?
|
| Polytetrafluoroethylene | 1 | 2008 | 245 | 0.280 |
Why?
|
| Recurrence | 11 | 2023 | 8482 | 0.280 |
Why?
|
| Vascular Surgical Procedures | 3 | 2007 | 1475 | 0.270 |
Why?
|
| Receptors, Estrogen | 5 | 1999 | 2210 | 0.270 |
Why?
|
| Neuroanatomy | 1 | 2006 | 70 | 0.270 |
Why?
|
| Health Care Reform | 1 | 2015 | 1245 | 0.270 |
Why?
|
| Antidiuretic Agents | 1 | 2006 | 21 | 0.270 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2006 | 20 | 0.260 |
Why?
|
| Rhizotomy | 2 | 2005 | 30 | 0.260 |
Why?
|
| Hypothalamus | 4 | 2010 | 998 | 0.260 |
Why?
|
| Central Nervous System Neoplasms | 4 | 2005 | 916 | 0.260 |
Why?
|
| Bone Substitutes | 1 | 2008 | 236 | 0.260 |
Why?
|
| Combined Modality Therapy | 22 | 2020 | 8552 | 0.260 |
Why?
|
| Vascular Diseases | 4 | 2006 | 1182 | 0.260 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2015 | 1200 | 0.250 |
Why?
|
| Radiotherapy, Adjuvant | 9 | 2020 | 1791 | 0.250 |
Why?
|
| Carmustine | 3 | 2003 | 138 | 0.250 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 1416 | 0.250 |
Why?
|
| Retreatment | 2 | 2024 | 600 | 0.250 |
Why?
|
| Treatment Failure | 7 | 2018 | 2648 | 0.250 |
Why?
|
| Somatostatin | 4 | 2005 | 447 | 0.240 |
Why?
|
| Cerebral Arteries | 2 | 1998 | 493 | 0.240 |
Why?
|
| Infarction | 1 | 2006 | 248 | 0.240 |
Why?
|
| Spinal Nerve Roots | 1 | 2005 | 121 | 0.240 |
Why?
|
| Cranial Fossa, Posterior | 3 | 2000 | 135 | 0.240 |
Why?
|
| General Surgery | 3 | 2005 | 1678 | 0.240 |
Why?
|
| United States | 33 | 2021 | 72461 | 0.230 |
Why?
|
| Ultrasonography, Doppler | 2 | 2016 | 465 | 0.230 |
Why?
|
| Adenoma, Basophil | 1 | 2003 | 1 | 0.230 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 2634 | 0.230 |
Why?
|
| Specialization | 2 | 2007 | 778 | 0.230 |
Why?
|
| Blood Loss, Surgical | 3 | 2005 | 656 | 0.230 |
Why?
|
| Brain Concussion | 1 | 2015 | 1394 | 0.230 |
Why?
|
| Hypothalamic Diseases | 1 | 2005 | 134 | 0.230 |
Why?
|
| Bromocriptine | 9 | 2005 | 93 | 0.220 |
Why?
|
| Cerebral Angiography | 7 | 2016 | 1274 | 0.220 |
Why?
|
| Drug Implants | 2 | 2003 | 230 | 0.220 |
Why?
|
| Perioperative Care | 3 | 2012 | 1037 | 0.220 |
Why?
|
| Cerebral Palsy | 2 | 2005 | 471 | 0.220 |
Why?
|
| Hydrocephalus | 9 | 2012 | 763 | 0.220 |
Why?
|
| Time Factors | 24 | 2018 | 40165 | 0.210 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2006 | 2828 | 0.210 |
Why?
|
| Adrenal Glands | 1 | 2005 | 554 | 0.210 |
Why?
|
| History, 21st Century | 3 | 2016 | 1575 | 0.210 |
Why?
|
| Drug Therapy | 1 | 2006 | 504 | 0.210 |
Why?
|
| Famous Persons | 2 | 2015 | 109 | 0.210 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2002 | 55 | 0.210 |
Why?
|
| Epilepsy, Temporal Lobe | 5 | 1997 | 387 | 0.210 |
Why?
|
| Thalamus | 3 | 1999 | 1041 | 0.200 |
Why?
|
| Neurilemmoma | 4 | 2003 | 523 | 0.200 |
Why?
|
| Incidence | 9 | 2016 | 21392 | 0.200 |
Why?
|
| Globus Pallidus | 3 | 1999 | 249 | 0.200 |
Why?
|
| Immunohistochemistry | 18 | 2016 | 11071 | 0.200 |
Why?
|
| Craniocerebral Trauma | 6 | 2010 | 491 | 0.200 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 2001 | 13 | 0.200 |
Why?
|
| World Health Organization | 4 | 2021 | 1312 | 0.200 |
Why?
|
| Follicle Stimulating Hormone | 6 | 2016 | 725 | 0.190 |
Why?
|
| Brain | 13 | 2010 | 26951 | 0.190 |
Why?
|
| Fluoroscopy | 2 | 2006 | 948 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 38 | 2015 | 20509 | 0.190 |
Why?
|
| Ganglioglioma | 1 | 2001 | 36 | 0.190 |
Why?
|
| Carcinoma, Small Cell | 2 | 1999 | 416 | 0.190 |
Why?
|
| Pituitary Irradiation | 1 | 2000 | 14 | 0.190 |
Why?
|
| Neoplasm Transplantation | 7 | 1993 | 2014 | 0.180 |
Why?
|
| Therapy, Computer-Assisted | 2 | 2001 | 267 | 0.180 |
Why?
|
| Body Constitution | 1 | 2021 | 273 | 0.180 |
Why?
|
| Brain Diseases | 5 | 1995 | 1540 | 0.180 |
Why?
|
| Medicine | 2 | 2007 | 943 | 0.180 |
Why?
|
| Galactorrhea | 7 | 2016 | 22 | 0.180 |
Why?
|
| Patient Selection | 3 | 2010 | 4283 | 0.180 |
Why?
|
| Gait | 2 | 2005 | 812 | 0.170 |
Why?
|
| Neoplasm Metastasis | 6 | 2006 | 4902 | 0.170 |
Why?
|
| Lip | 2 | 2002 | 197 | 0.170 |
Why?
|
| Granular Cell Tumor | 1 | 2019 | 48 | 0.170 |
Why?
|
| Peripheral Nerves | 1 | 2003 | 475 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2016 | 8950 | 0.170 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2003 | 618 | 0.170 |
Why?
|
| Temporal Lobe | 5 | 2002 | 1688 | 0.170 |
Why?
|
| Microscopy, Electron | 10 | 2000 | 2558 | 0.160 |
Why?
|
| Disease Management | 4 | 2020 | 2514 | 0.160 |
Why?
|
| Growth Disorders | 2 | 2005 | 653 | 0.160 |
Why?
|
| Neurology | 1 | 2007 | 779 | 0.160 |
Why?
|
| Databases, Factual | 7 | 2021 | 8035 | 0.160 |
Why?
|
| Growth Hormone-Releasing Hormone | 3 | 1997 | 128 | 0.160 |
Why?
|
| Cell Division | 5 | 1999 | 4463 | 0.160 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 1999 | 59 | 0.160 |
Why?
|
| Dissection | 2 | 2010 | 298 | 0.160 |
Why?
|
| Equipment Design | 7 | 2015 | 3520 | 0.160 |
Why?
|
| Child, Preschool | 32 | 2018 | 42063 | 0.160 |
Why?
|
| Periodicals as Topic | 3 | 2008 | 1469 | 0.160 |
Why?
|
| Electrodes, Implanted | 2 | 2007 | 833 | 0.160 |
Why?
|
| Absorbable Implants | 1 | 2001 | 345 | 0.150 |
Why?
|
| Computer Systems | 2 | 2015 | 470 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 10 | 1996 | 1705 | 0.150 |
Why?
|
| Cohort Studies | 12 | 2024 | 41335 | 0.150 |
Why?
|
| Neoplasms, Radiation-Induced | 3 | 2005 | 547 | 0.150 |
Why?
|
| Survival Rate | 12 | 2017 | 12808 | 0.150 |
Why?
|
| Radiography | 12 | 2011 | 6965 | 0.150 |
Why?
|
| Health Services | 2 | 2013 | 753 | 0.150 |
Why?
|
| Physician's Role | 1 | 2004 | 918 | 0.150 |
Why?
|
| Reflex, Babinski | 1 | 1997 | 7 | 0.150 |
Why?
|
| Hematoporphyrin Photoradiation | 2 | 1987 | 17 | 0.150 |
Why?
|
| Paresthesia | 2 | 2003 | 162 | 0.150 |
Why?
|
| Spinal Neoplasms | 2 | 1995 | 716 | 0.150 |
Why?
|
| Cerebral Ventriculography | 3 | 2013 | 44 | 0.150 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 5325 | 0.140 |
Why?
|
| Cerebellar Neoplasms | 6 | 1999 | 587 | 0.140 |
Why?
|
| Basal Ganglia | 2 | 1999 | 552 | 0.140 |
Why?
|
| Neuroma, Acoustic | 6 | 1985 | 459 | 0.140 |
Why?
|
| Antibodies, Antinuclear | 2 | 2010 | 344 | 0.140 |
Why?
|
| Hypothalamic Neoplasms | 3 | 2006 | 21 | 0.140 |
Why?
|
| Benchmarking | 2 | 2016 | 1044 | 0.140 |
Why?
|
| Surgical Instruments | 5 | 2010 | 385 | 0.140 |
Why?
|
| Methods | 15 | 1990 | 1074 | 0.140 |
Why?
|
| Skull | 3 | 2011 | 815 | 0.140 |
Why?
|
| Bone Cements | 1 | 2018 | 324 | 0.140 |
Why?
|
| Risk Factors | 16 | 2024 | 74359 | 0.140 |
Why?
|
| Hypothyroidism | 4 | 2006 | 665 | 0.130 |
Why?
|
| Incisor | 1 | 1997 | 174 | 0.130 |
Why?
|
| Austria | 3 | 2006 | 206 | 0.130 |
Why?
|
| Aneurysm, False | 2 | 2014 | 257 | 0.130 |
Why?
|
| Neurophysiology | 1 | 1997 | 144 | 0.130 |
Why?
|
| Fibrosarcoma | 1 | 1998 | 308 | 0.130 |
Why?
|
| Glucocorticoids | 3 | 2012 | 2145 | 0.130 |
Why?
|
| Adrenalectomy | 2 | 2009 | 348 | 0.130 |
Why?
|
| Pituitary Gland, Anterior | 8 | 1998 | 142 | 0.130 |
Why?
|
| Arachnoid | 2 | 2024 | 50 | 0.130 |
Why?
|
| Neurosciences | 1 | 2000 | 353 | 0.130 |
Why?
|
| Hemangioblastoma | 1 | 1996 | 63 | 0.130 |
Why?
|
| Cranial Nerves | 1 | 2016 | 98 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2017 | 6544 | 0.130 |
Why?
|
| Antineoplastic Agents | 6 | 2010 | 13630 | 0.130 |
Why?
|
| Cerebral Veins | 1 | 1997 | 157 | 0.130 |
Why?
|
| Defensive Medicine | 1 | 2015 | 47 | 0.130 |
Why?
|
| Hemorrhage | 2 | 2015 | 3600 | 0.130 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 494 | 0.130 |
Why?
|
| Biopsy | 6 | 2011 | 6771 | 0.130 |
Why?
|
| Obesity | 3 | 2022 | 12922 | 0.130 |
Why?
|
| Nasal Septum | 4 | 1992 | 130 | 0.130 |
Why?
|
| Ploidies | 2 | 2006 | 275 | 0.130 |
Why?
|
| Chondroma | 1 | 1995 | 53 | 0.130 |
Why?
|
| Length of Stay | 4 | 2018 | 6479 | 0.130 |
Why?
|
| Calcium Pyrophosphate | 1 | 1995 | 53 | 0.130 |
Why?
|
| Head Injuries, Penetrating | 1 | 2015 | 28 | 0.130 |
Why?
|
| Prevalence | 6 | 2017 | 15687 | 0.120 |
Why?
|
| Equipment Safety | 1 | 2016 | 253 | 0.120 |
Why?
|
| Electrosurgery | 2 | 2005 | 51 | 0.120 |
Why?
|
| Arginine Vasopressin | 1 | 2015 | 125 | 0.120 |
Why?
|
| Central Nervous System Diseases | 1 | 1999 | 521 | 0.120 |
Why?
|
| Hematoporphyrins | 3 | 1986 | 23 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2005 | 2754 | 0.120 |
Why?
|
| Cerebral Hemorrhage | 6 | 2012 | 2660 | 0.120 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2016 | 334 | 0.120 |
Why?
|
| Endocrinology | 3 | 2014 | 443 | 0.120 |
Why?
|
| Nose Neoplasms | 4 | 1998 | 249 | 0.120 |
Why?
|
| Chromosomes, Human | 1 | 2016 | 442 | 0.120 |
Why?
|
| Peer Review, Research | 1 | 1997 | 340 | 0.120 |
Why?
|
| Intracranial Hemorrhages | 3 | 2015 | 844 | 0.120 |
Why?
|
| Hydrocephalus, Normal Pressure | 4 | 1987 | 99 | 0.120 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2007 | 3529 | 0.120 |
Why?
|
| Tumor Burden | 2 | 2010 | 1895 | 0.120 |
Why?
|
| Petrosal Sinus Sampling | 2 | 2007 | 22 | 0.120 |
Why?
|
| Logistic Models | 4 | 2017 | 13314 | 0.110 |
Why?
|
| Abducens Nerve | 1 | 1993 | 28 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2017 | 8515 | 0.110 |
Why?
|
| Testosterone | 3 | 2010 | 2470 | 0.110 |
Why?
|
| Intraoperative Period | 2 | 2010 | 516 | 0.110 |
Why?
|
| Anesthetics, Intravenous | 1 | 2017 | 397 | 0.110 |
Why?
|
| Inflammation | 3 | 2015 | 10756 | 0.110 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 508 | 0.110 |
Why?
|
| Anemia | 1 | 2003 | 1511 | 0.110 |
Why?
|
| RNA, Messenger | 11 | 2016 | 12766 | 0.110 |
Why?
|
| Accessory Nerve | 1 | 1993 | 11 | 0.110 |
Why?
|
| Longevity | 1 | 2021 | 1050 | 0.110 |
Why?
|
| Historiography | 1 | 1993 | 8 | 0.110 |
Why?
|
| Twins, Monozygotic | 1 | 2015 | 469 | 0.110 |
Why?
|
| Nervous System Malformations | 1 | 2015 | 244 | 0.110 |
Why?
|
| Foundations | 1 | 1993 | 97 | 0.110 |
Why?
|
| Abdomen | 1 | 2019 | 1130 | 0.110 |
Why?
|
| Thyroxine | 1 | 2016 | 667 | 0.110 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 2 | 2002 | 15 | 0.110 |
Why?
|
| Epilepsies, Partial | 3 | 1988 | 430 | 0.110 |
Why?
|
| Quality of Life | 7 | 2016 | 13308 | 0.110 |
Why?
|
| Prospective Studies | 12 | 2022 | 54303 | 0.100 |
Why?
|
| Demyelinating Diseases | 1 | 1995 | 351 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 1999 | 1529 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2007 | 3976 | 0.100 |
Why?
|
| Rats | 14 | 2012 | 23711 | 0.100 |
Why?
|
| Atrophy | 3 | 2007 | 1627 | 0.100 |
Why?
|
| Medulloblastoma | 4 | 1999 | 679 | 0.100 |
Why?
|
| Lactotrophs | 1 | 2012 | 3 | 0.100 |
Why?
|
| Homicide | 1 | 2015 | 295 | 0.100 |
Why?
|
| SEER Program | 1 | 2017 | 1530 | 0.100 |
Why?
|
| Lumbar Vertebrae | 2 | 2018 | 1868 | 0.100 |
Why?
|
| Photochemotherapy | 3 | 1987 | 820 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2006 | 2919 | 0.100 |
Why?
|
| Neoplasm Proteins | 4 | 2015 | 3610 | 0.100 |
Why?
|
| Paralysis | 1 | 1993 | 251 | 0.100 |
Why?
|
| Facial Nerve | 2 | 1993 | 277 | 0.100 |
Why?
|
| Laminectomy | 3 | 2005 | 224 | 0.100 |
Why?
|
| Cerebral Ventricles | 3 | 1989 | 542 | 0.100 |
Why?
|
| Hemostasis | 1 | 2014 | 468 | 0.100 |
Why?
|
| Supratentorial Neoplasms | 2 | 1990 | 159 | 0.100 |
Why?
|
| Gene Expression | 4 | 2016 | 7588 | 0.100 |
Why?
|
| History, 18th Century | 3 | 2007 | 207 | 0.100 |
Why?
|
| DNA Copy Number Variations | 2 | 2017 | 2013 | 0.100 |
Why?
|
| Thyroid Gland | 2 | 2017 | 1168 | 0.100 |
Why?
|
| Glycoprotein Hormones, alpha Subunit | 2 | 1994 | 95 | 0.100 |
Why?
|
| Virginia | 3 | 2007 | 116 | 0.090 |
Why?
|
| Blood Vessels | 3 | 2016 | 1112 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2017 | 2362 | 0.090 |
Why?
|
| Multivariate Analysis | 6 | 2017 | 12159 | 0.090 |
Why?
|
| Argentina | 1 | 2011 | 245 | 0.090 |
Why?
|
| Contractile Proteins | 1 | 2012 | 240 | 0.090 |
Why?
|
| Patient Care Team | 3 | 2015 | 2511 | 0.090 |
Why?
|
| Radiotherapy Dosage | 6 | 2007 | 2897 | 0.090 |
Why?
|
| Animals | 23 | 2018 | 167963 | 0.090 |
Why?
|
| Parietal Lobe | 1 | 2016 | 850 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 5 | 2012 | 6131 | 0.090 |
Why?
|
| Seizures | 4 | 2016 | 2917 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2017 | 650 | 0.090 |
Why?
|
| Pitch Discrimination | 1 | 2010 | 29 | 0.090 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2010 | 83 | 0.090 |
Why?
|
| Risk | 6 | 2016 | 9631 | 0.090 |
Why?
|
| Sex Factors | 13 | 2014 | 10547 | 0.090 |
Why?
|
| Histocytochemistry | 4 | 2007 | 700 | 0.090 |
Why?
|
| Deamino Arginine Vasopressin | 2 | 2010 | 87 | 0.090 |
Why?
|
| Vasospasm, Intracranial | 1 | 2012 | 215 | 0.090 |
Why?
|
| Vietnam Conflict | 1 | 2010 | 100 | 0.090 |
Why?
|
| Databases as Topic | 2 | 2005 | 474 | 0.090 |
Why?
|
| Radionuclide Imaging | 1 | 2014 | 1975 | 0.090 |
Why?
|
| Syndrome | 1 | 2016 | 3280 | 0.090 |
Why?
|
| Pathology, Surgical | 1 | 2011 | 151 | 0.090 |
Why?
|
| Predictive Value of Tests | 6 | 2021 | 15289 | 0.090 |
Why?
|
| COUP Transcription Factor I | 1 | 2009 | 12 | 0.090 |
Why?
|
| Pregnancy | 12 | 2016 | 29749 | 0.090 |
Why?
|
| Molecular Imaging | 1 | 2016 | 818 | 0.090 |
Why?
|
| Social Support | 1 | 2019 | 2145 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 693 | 0.080 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1578 | 0.080 |
Why?
|
| Epidermal Cyst | 1 | 2010 | 64 | 0.080 |
Why?
|
| Wounds, Penetrating | 2 | 2010 | 306 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 2192 | 0.080 |
Why?
|
| Boxing | 1 | 2009 | 17 | 0.080 |
Why?
|
| Fluorescence | 1 | 2012 | 751 | 0.080 |
Why?
|
| Sarcoma | 1 | 2020 | 1786 | 0.080 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2012 | 485 | 0.080 |
Why?
|
| Wounds, Gunshot | 1 | 2015 | 581 | 0.080 |
Why?
|
| Psychomotor Agitation | 1 | 2011 | 305 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1484 | 0.080 |
Why?
|
| Radiation-Sensitizing Agents | 2 | 1998 | 345 | 0.080 |
Why?
|
| Ventriculostomy | 1 | 2010 | 131 | 0.080 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 1717 | 0.080 |
Why?
|
| Pseudotumor Cerebri | 1 | 2010 | 108 | 0.080 |
Why?
|
| France | 2 | 2003 | 511 | 0.080 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2010 | 75 | 0.080 |
Why?
|
| Clinical Protocols | 2 | 2012 | 1440 | 0.080 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 2 | 2006 | 66 | 0.080 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 1988 | 21 | 0.080 |
Why?
|
| Reflex, Stretch | 2 | 2005 | 23 | 0.080 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 12531 | 0.080 |
Why?
|
| Calcinosis | 2 | 1995 | 1476 | 0.080 |
Why?
|
| Spasm | 2 | 1986 | 131 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1728 | 0.080 |
Why?
|
| Guideline Adherence | 2 | 2016 | 2283 | 0.080 |
Why?
|
| Piperidines | 1 | 2017 | 1650 | 0.080 |
Why?
|
| Receptors, Somatotropin | 2 | 2005 | 58 | 0.080 |
Why?
|
| Workers' Compensation | 2 | 1999 | 150 | 0.080 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 2002 | 586 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 4573 | 0.070 |
Why?
|
| Interprofessional Relations | 2 | 2005 | 989 | 0.070 |
Why?
|
| Radiotherapy | 4 | 2008 | 1504 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 1998 | 1446 | 0.070 |
Why?
|
| Education, Medical, Graduate | 2 | 2005 | 2363 | 0.070 |
Why?
|
| Forecasting | 3 | 2005 | 2932 | 0.070 |
Why?
|
| Chi-Square Distribution | 4 | 2017 | 3465 | 0.070 |
Why?
|
| Adenoma, Chromophobe | 4 | 1983 | 16 | 0.070 |
Why?
|
| Amenorrhea | 5 | 2005 | 480 | 0.070 |
Why?
|
| History, Ancient | 1 | 2008 | 211 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2012 | 23376 | 0.070 |
Why?
|
| Dacarbazine | 1 | 2010 | 560 | 0.070 |
Why?
|
| Visual Fields | 6 | 2016 | 1054 | 0.070 |
Why?
|
| Anesthesia | 4 | 2015 | 1584 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2007 | 7818 | 0.070 |
Why?
|
| Luteinizing Hormone | 5 | 1998 | 820 | 0.070 |
Why?
|
| Hirsutism | 2 | 2005 | 68 | 0.070 |
Why?
|
| Soccer | 1 | 2009 | 141 | 0.070 |
Why?
|
| Pyrones | 1 | 2007 | 36 | 0.070 |
Why?
|
| Rats, Inbred Strains | 7 | 1992 | 2094 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 1986 | 3765 | 0.070 |
Why?
|
| Geologic Sediments | 1 | 2007 | 79 | 0.070 |
Why?
|
| Anticoagulants | 4 | 2015 | 4897 | 0.070 |
Why?
|
| Reference Values | 4 | 2011 | 4925 | 0.070 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 14495 | 0.070 |
Why?
|
| International Cooperation | 1 | 1993 | 1433 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2012 | 5870 | 0.070 |
Why?
|
| Hemangioma, Cavernous | 1 | 1987 | 107 | 0.070 |
Why?
|
| Necrosis | 2 | 2015 | 1612 | 0.070 |
Why?
|
| Pineal Gland | 2 | 1985 | 157 | 0.070 |
Why?
|
| Water Microbiology | 1 | 2007 | 113 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 1135 | 0.070 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1995 | 1152 | 0.070 |
Why?
|
| Dexamethasone | 3 | 2012 | 1927 | 0.070 |
Why?
|
| Pergolide | 2 | 2005 | 2 | 0.070 |
Why?
|
| Lymphocytes, Null | 1 | 2005 | 13 | 0.070 |
Why?
|
| Facial Nerve Diseases | 1 | 1986 | 49 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3242 | 0.070 |
Why?
|
| Pinealoma | 3 | 1985 | 51 | 0.070 |
Why?
|
| Arnold-Chiari Malformation | 1 | 1988 | 158 | 0.070 |
Why?
|
| Glycoproteins | 3 | 2011 | 2208 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2016 | 2985 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2007 | 24123 | 0.070 |
Why?
|
| Meningitis, Bacterial | 2 | 2001 | 221 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2008 | 5039 | 0.070 |
Why?
|
| Disease-Free Survival | 4 | 2015 | 6828 | 0.070 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 1994 | 550 | 0.070 |
Why?
|
| Subdural Effusion | 1 | 2005 | 19 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 2176 | 0.060 |
Why?
|
| Pituitary Gland, Posterior | 1 | 2005 | 42 | 0.060 |
Why?
|
| International Educational Exchange | 1 | 2005 | 49 | 0.060 |
Why?
|
| Embolization, Therapeutic | 2 | 2014 | 1413 | 0.060 |
Why?
|
| Review Literature as Topic | 1 | 2008 | 349 | 0.060 |
Why?
|
| Cerebral Infarction | 2 | 2008 | 982 | 0.060 |
Why?
|
| Choristoma | 2 | 1986 | 207 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2007 | 818 | 0.060 |
Why?
|
| Hormones, Ectopic | 3 | 1994 | 37 | 0.060 |
Why?
|
| Hospitals | 2 | 2015 | 3928 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 1988 | 717 | 0.060 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2010 | 622 | 0.060 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 283 | 0.060 |
Why?
|
| Facial Muscles | 1 | 1986 | 159 | 0.060 |
Why?
|
| Dominance, Cerebral | 2 | 2005 | 622 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2006 | 319 | 0.060 |
Why?
|
| Cranial Fossa, Middle | 1 | 2005 | 29 | 0.060 |
Why?
|
| Algorithms | 4 | 2006 | 13981 | 0.060 |
Why?
|
| Hamartoma | 2 | 1986 | 235 | 0.060 |
Why?
|
| Health Status | 2 | 2017 | 4081 | 0.060 |
Why?
|
| Eye Neoplasms | 1 | 1987 | 306 | 0.060 |
Why?
|
| Carotid Arteries | 2 | 2009 | 951 | 0.060 |
Why?
|
| Trigeminal Neuralgia | 1 | 1986 | 106 | 0.060 |
Why?
|
| Rats, Zucker | 1 | 2005 | 132 | 0.060 |
Why?
|
| Correspondence as Topic | 1 | 2005 | 30 | 0.060 |
Why?
|
| Actuarial Analysis | 1 | 2005 | 374 | 0.060 |
Why?
|
| Putamen | 1 | 2006 | 291 | 0.060 |
Why?
|
| Chicago | 1 | 2005 | 244 | 0.060 |
Why?
|
| Basilar Artery | 1 | 2006 | 205 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 3 | 2002 | 552 | 0.060 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3865 | 0.060 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2005 | 109 | 0.060 |
Why?
|
| Meninges | 1 | 1986 | 197 | 0.060 |
Why?
|
| Protoporphyrins | 1 | 2005 | 165 | 0.060 |
Why?
|
| Cell Proliferation | 4 | 2012 | 10446 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 7475 | 0.060 |
Why?
|
| Migraine Disorders | 1 | 2017 | 1693 | 0.060 |
Why?
|
| Parkinson Disease | 3 | 2006 | 2859 | 0.060 |
Why?
|
| Hippocampus | 1 | 1997 | 3738 | 0.060 |
Why?
|
| In Situ Hybridization | 3 | 1999 | 1900 | 0.060 |
Why?
|
| Hemangiopericytoma | 2 | 2002 | 71 | 0.060 |
Why?
|
| Nuclear Proteins | 2 | 1996 | 5791 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 1913 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 2053 | 0.060 |
Why?
|
| Friends | 1 | 2005 | 150 | 0.060 |
Why?
|
| Hyperpituitarism | 1 | 2003 | 2 | 0.060 |
Why?
|
| Hyperthyroidism | 1 | 2006 | 291 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1994 | 2471 | 0.060 |
Why?
|
| Age Factors | 15 | 2014 | 18416 | 0.060 |
Why?
|
| Perception | 1 | 2010 | 1195 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2013 | 1588 | 0.060 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2004 | 173 | 0.050 |
Why?
|
| Phytohemagglutinins | 3 | 1993 | 168 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 1989 | 1436 | 0.050 |
Why?
|
| Carotid Artery Diseases | 3 | 1979 | 883 | 0.050 |
Why?
|
| Phenotype | 2 | 2016 | 16546 | 0.050 |
Why?
|
| Premedication | 2 | 1998 | 253 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1995 | 2003 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1173 | 0.050 |
Why?
|
| Electromyography | 2 | 2005 | 1388 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2011 | 1347 | 0.050 |
Why?
|
| Electroencephalography | 6 | 2016 | 6189 | 0.050 |
Why?
|
| Diverticulum | 1 | 2024 | 137 | 0.050 |
Why?
|
| Graves Disease | 1 | 2004 | 239 | 0.050 |
Why?
|
| Boston | 1 | 2015 | 9280 | 0.050 |
Why?
|
| Uterine Neoplasms | 1 | 2011 | 1439 | 0.050 |
Why?
|
| Hypogonadism | 3 | 2010 | 801 | 0.050 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2005 | 238 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3696 | 0.050 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2005 | 323 | 0.050 |
Why?
|
| Critical Care | 1 | 2015 | 2699 | 0.050 |
Why?
|
| Complementary Therapies | 1 | 2006 | 486 | 0.050 |
Why?
|
| Multiple Endocrine Neoplasia | 3 | 1987 | 25 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 1984 | 700 | 0.050 |
Why?
|
| Infant | 17 | 2014 | 36060 | 0.050 |
Why?
|
| Contraceptives, Oral | 2 | 2022 | 554 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2007 | 1199 | 0.050 |
Why?
|
| Spinal Cord Diseases | 1 | 1985 | 293 | 0.050 |
Why?
|
| Lung Neoplasms | 4 | 1999 | 13262 | 0.050 |
Why?
|
| Posture | 2 | 2005 | 953 | 0.050 |
Why?
|
| Equipment Failure | 2 | 2012 | 577 | 0.050 |
Why?
|
| Surgical Equipment | 2 | 2012 | 57 | 0.050 |
Why?
|
| Hematocrit | 1 | 2003 | 629 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2017 | 3836 | 0.050 |
Why?
|
| Transplantation, Heterologous | 4 | 1993 | 2379 | 0.050 |
Why?
|
| Range of Motion, Articular | 2 | 2005 | 1583 | 0.050 |
Why?
|
| Acute Disease | 2 | 2007 | 7269 | 0.050 |
Why?
|
| Clinical Competence | 2 | 2008 | 4783 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 9185 | 0.050 |
Why?
|
| Hospitals, Military | 2 | 1999 | 62 | 0.050 |
Why?
|
| Advisory Committees | 1 | 2005 | 788 | 0.050 |
Why?
|
| Hypertension | 5 | 2015 | 8594 | 0.050 |
Why?
|
| Disasters | 1 | 2007 | 517 | 0.050 |
Why?
|
| Retinal Diseases | 1 | 1987 | 702 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2007 | 3602 | 0.050 |
Why?
|
| Drug Design | 1 | 2006 | 1061 | 0.050 |
Why?
|
| Guidelines as Topic | 2 | 2012 | 1392 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2005 | 805 | 0.050 |
Why?
|
| Neurologic Examination | 3 | 2000 | 916 | 0.050 |
Why?
|
| Language | 1 | 2010 | 1533 | 0.050 |
Why?
|
| Microscopy | 1 | 2005 | 885 | 0.040 |
Why?
|
| Blood-Brain Barrier | 2 | 2002 | 1019 | 0.040 |
Why?
|
| Endovascular Procedures | 1 | 2014 | 2165 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1993 | 4490 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2011 | 4000 | 0.040 |
Why?
|
| Diploidy | 1 | 2000 | 132 | 0.040 |
Why?
|
| Giant Cell Arteritis | 1 | 2004 | 295 | 0.040 |
Why?
|
| Anxiety | 2 | 2013 | 4538 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 1999 | 1628 | 0.040 |
Why?
|
| Nervous System Diseases | 3 | 2012 | 1647 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 1983 | 454 | 0.040 |
Why?
|
| Otolaryngology | 1 | 2007 | 685 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2005 | 604 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 2003 | 562 | 0.040 |
Why?
|
| Spinal Cord | 1 | 1988 | 1817 | 0.040 |
Why?
|
| Cerebral Cortex | 7 | 1991 | 5761 | 0.040 |
Why?
|
| Atlanto-Occipital Joint | 1 | 1979 | 34 | 0.040 |
Why?
|
| Withholding Treatment | 1 | 2004 | 613 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 2001 | 378 | 0.040 |
Why?
|
| Drug Administration Schedule | 3 | 2003 | 4899 | 0.040 |
Why?
|
| Circadian Rhythm | 2 | 2021 | 2571 | 0.040 |
Why?
|
| Minnesota | 7 | 1989 | 340 | 0.040 |
Why?
|
| Hormones | 3 | 1988 | 867 | 0.040 |
Why?
|
| Indoles | 1 | 1987 | 1829 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 20080 | 0.040 |
Why?
|
| Diencephalon | 1 | 1999 | 54 | 0.040 |
Why?
|
| Steroids | 1 | 2004 | 928 | 0.040 |
Why?
|
| Erythropoiesis | 1 | 2003 | 682 | 0.040 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 1982 | 367 | 0.040 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 1999 | 44 | 0.040 |
Why?
|
| Cell Movement | 6 | 1994 | 5206 | 0.040 |
Why?
|
| Estrogen Receptor Modulators | 1 | 1999 | 58 | 0.040 |
Why?
|
| Polyesters | 1 | 2001 | 372 | 0.040 |
Why?
|
| Physicians | 1 | 2017 | 4591 | 0.040 |
Why?
|
| Carotid Artery Injuries | 1 | 1999 | 96 | 0.040 |
Why?
|
| Peptides | 1 | 2011 | 4354 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2003 | 709 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 1994 | 941 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2008 | 4122 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2005 | 1617 | 0.040 |
Why?
|
| Lovastatin | 1 | 1998 | 116 | 0.040 |
Why?
|
| Cerebellum | 3 | 1985 | 1496 | 0.040 |
Why?
|
| Infant, Newborn | 6 | 2014 | 26181 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1997 | 1543 | 0.040 |
Why?
|
| Data Display | 1 | 1999 | 174 | 0.040 |
Why?
|
| Oligodendroglioma | 4 | 1989 | 279 | 0.040 |
Why?
|
| Rhinoplasty | 2 | 1997 | 238 | 0.040 |
Why?
|
| Emotions | 1 | 2010 | 2734 | 0.040 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 1998 | 58 | 0.040 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 1980 | 241 | 0.040 |
Why?
|
| Receptors, Drug | 1 | 1998 | 157 | 0.040 |
Why?
|
| Estrogen Receptor beta | 1 | 1998 | 168 | 0.040 |
Why?
|
| Levodopa | 1 | 1998 | 217 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2015 | 7408 | 0.040 |
Why?
|
| Microelectrodes | 1 | 1999 | 304 | 0.040 |
Why?
|
| Radiation Dosage | 4 | 2006 | 1958 | 0.040 |
Why?
|
| Bone Plates | 1 | 2001 | 465 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 25942 | 0.040 |
Why?
|
| Antiparkinson Agents | 1 | 1998 | 183 | 0.040 |
Why?
|
| Internet | 2 | 2014 | 3078 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3442 | 0.040 |
Why?
|
| Receptors, Progesterone | 2 | 1994 | 1130 | 0.040 |
Why?
|
| Pediatrics | 2 | 2005 | 3586 | 0.040 |
Why?
|
| Eponyms | 1 | 1997 | 14 | 0.040 |
Why?
|
| Occipital Bone | 1 | 1997 | 55 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2012 | 643 | 0.040 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2003 | 708 | 0.040 |
Why?
|
| Facial Pain | 1 | 1998 | 120 | 0.040 |
Why?
|
| Hyperplasia | 4 | 2011 | 1155 | 0.040 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 1998 | 144 | 0.040 |
Why?
|
| Ophthalmoplegia | 1 | 1998 | 168 | 0.040 |
Why?
|
| Cell Nucleus | 3 | 1996 | 2907 | 0.030 |
Why?
|
| Sulfurtransferases | 3 | 1985 | 17 | 0.030 |
Why?
|
| Stroke | 1 | 2019 | 9962 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 6068 | 0.030 |
Why?
|
| Thrombosis | 2 | 1999 | 3052 | 0.030 |
Why?
|
| Sclerosis | 1 | 1997 | 210 | 0.030 |
Why?
|
| Chromogranins | 1 | 2017 | 161 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2005 | 2533 | 0.030 |
Why?
|
| Adrenal Insufficiency | 2 | 2013 | 192 | 0.030 |
Why?
|
| Orbital Diseases | 1 | 1998 | 178 | 0.030 |
Why?
|
| Canada | 2 | 2015 | 2128 | 0.030 |
Why?
|
| Knee Joint | 1 | 2005 | 1663 | 0.030 |
Why?
|
| Cognition | 2 | 2017 | 6957 | 0.030 |
Why?
|
| Cause of Death | 2 | 1999 | 3725 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2873 | 0.030 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 289 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2003 | 961 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 3726 | 0.030 |
Why?
|
| Eye Diseases | 1 | 2001 | 651 | 0.030 |
Why?
|
| Europe | 3 | 1993 | 3441 | 0.030 |
Why?
|
| Medical Records | 2 | 2012 | 1407 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 2942 | 0.030 |
Why?
|
| Mitotic Index | 2 | 2010 | 161 | 0.030 |
Why?
|
| Arteriovenous Fistula | 1 | 1979 | 314 | 0.030 |
Why?
|
| Intelligence Tests | 2 | 1988 | 500 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2015 | 6796 | 0.030 |
Why?
|
| Postoperative Hemorrhage | 1 | 1999 | 422 | 0.030 |
Why?
|
| Suture Techniques | 3 | 1992 | 790 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2016 | 266 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.030 |
Why?
|
| Disease Progression | 2 | 2006 | 13502 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2006 | 2733 | 0.030 |
Why?
|
| Comorbidity | 2 | 2007 | 10551 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2003 | 5201 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2000 | 783 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2002 | 1268 | 0.030 |
Why?
|
| Astrocytes | 3 | 1992 | 1338 | 0.030 |
Why?
|
| Skull Fractures | 2 | 1989 | 202 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2017 | 555 | 0.030 |
Why?
|
| Motor Skills | 1 | 1998 | 520 | 0.030 |
Why?
|
| Weight Gain | 1 | 2005 | 2347 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2000 | 1871 | 0.030 |
Why?
|
| Lymphoma, B-Cell | 1 | 2002 | 935 | 0.030 |
Why?
|
| Lactates | 1 | 1996 | 404 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1998 | 534 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 17624 | 0.030 |
Why?
|
| Science | 1 | 1997 | 239 | 0.030 |
Why?
|
| Receptors, Growth Factor | 1 | 1996 | 326 | 0.030 |
Why?
|
| Drug Delivery Systems | 2 | 2006 | 2221 | 0.030 |
Why?
|
| Radiology, Interventional | 1 | 1999 | 475 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2006 | 6238 | 0.030 |
Why?
|
| Collagen | 2 | 1994 | 2636 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1998 | 563 | 0.030 |
Why?
|
| Microinjections | 1 | 2015 | 321 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1996 | 301 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 1998 | 580 | 0.030 |
Why?
|
| Epilepsy | 6 | 2007 | 3267 | 0.030 |
Why?
|
| Systems Integration | 1 | 2016 | 426 | 0.030 |
Why?
|
| Leg | 1 | 1999 | 1090 | 0.030 |
Why?
|
| Fetus | 2 | 1992 | 1859 | 0.030 |
Why?
|
| Facial Paralysis | 2 | 1993 | 345 | 0.030 |
Why?
|
| Tamoxifen | 1 | 1999 | 963 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2015 | 267 | 0.030 |
Why?
|
| Body Weight | 1 | 2005 | 4611 | 0.030 |
Why?
|
| Safety | 1 | 1999 | 1148 | 0.030 |
Why?
|
| Temperature | 1 | 2001 | 2221 | 0.030 |
Why?
|
| Choline | 1 | 1996 | 513 | 0.030 |
Why?
|
| Menopause | 1 | 2022 | 1640 | 0.030 |
Why?
|
| Teratoma | 2 | 1988 | 403 | 0.030 |
Why?
|
| Health Care Surveys | 2 | 2014 | 2435 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 848 | 0.030 |
Why?
|
| Polymers | 1 | 2001 | 1621 | 0.030 |
Why?
|
| Models, Psychological | 1 | 1997 | 827 | 0.030 |
Why?
|
| Alanine | 1 | 1996 | 606 | 0.030 |
Why?
|
| Myelography | 2 | 1985 | 72 | 0.030 |
Why?
|
| Brachytherapy | 1 | 2001 | 1238 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1999 | 908 | 0.030 |
Why?
|
| Blindness | 1 | 1977 | 582 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 3616 | 0.030 |
Why?
|
| Intracranial Hypertension | 1 | 2015 | 193 | 0.030 |
Why?
|
| Cervical Vertebrae | 1 | 1999 | 978 | 0.030 |
Why?
|
| Lymphocytosis | 1 | 1994 | 119 | 0.030 |
Why?
|
| Dihydroxyphenylalanine | 2 | 2006 | 74 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2022 | 22053 | 0.030 |
Why?
|
| Cranial Nerve Diseases | 1 | 1993 | 112 | 0.030 |
Why?
|
| Cadaver | 1 | 1997 | 1345 | 0.030 |
Why?
|
| Radiation Injuries | 2 | 1999 | 1183 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2003 | 10182 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2017 | 1218 | 0.030 |
Why?
|
| Receptor, erbB-2 | 2 | 1994 | 2554 | 0.030 |
Why?
|
| Ethmoid Bone | 1 | 1992 | 35 | 0.030 |
Why?
|
| Drug Evaluation | 2 | 2006 | 641 | 0.030 |
Why?
|
| Exons | 1 | 1998 | 2388 | 0.030 |
Why?
|
| Functional Laterality | 2 | 1997 | 2253 | 0.030 |
Why?
|
| Neoplasm Staging | 5 | 2003 | 11152 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2006 | 3164 | 0.030 |
Why?
|
| Laminin | 1 | 1994 | 405 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2015 | 633 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 940 | 0.030 |
Why?
|
| Ghana | 1 | 1993 | 312 | 0.030 |
Why?
|
| Reference Standards | 1 | 1996 | 1004 | 0.030 |
Why?
|
| Research | 1 | 2000 | 1974 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1993 | 8158 | 0.020 |
Why?
|
| Schools, Medical | 1 | 1998 | 878 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 1994 | 238 | 0.020 |
Why?
|
| Registries | 3 | 2014 | 8469 | 0.020 |
Why?
|
| Lumbosacral Region | 2 | 1997 | 291 | 0.020 |
Why?
|
| Military Personnel | 2 | 1999 | 1244 | 0.020 |
Why?
|
| Audiometry | 2 | 1983 | 253 | 0.020 |
Why?
|
| Adrenal Cortex | 1 | 2012 | 134 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2016 | 8555 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2017 | 9716 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 1544 | 0.020 |
Why?
|
| Oncogenes | 1 | 2017 | 1220 | 0.020 |
Why?
|
| Free Radicals | 1 | 1991 | 238 | 0.020 |
Why?
|
| Fixatives | 1 | 2011 | 91 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1998 | 1245 | 0.020 |
Why?
|
| DNA | 1 | 2005 | 7233 | 0.020 |
Why?
|
| Molecular Biology | 1 | 1995 | 580 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2004 | 3726 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1996 | 1091 | 0.020 |
Why?
|
| Warfarin | 1 | 1999 | 1518 | 0.020 |
Why?
|
| Double-Blind Method | 4 | 2006 | 12427 | 0.020 |
Why?
|
| Lactic Acid | 1 | 1996 | 1134 | 0.020 |
Why?
|
| Internationality | 1 | 2016 | 1004 | 0.020 |
Why?
|
| Proteoglycans | 1 | 1994 | 801 | 0.020 |
Why?
|
| Benzoquinones | 1 | 2011 | 198 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 1994 | 1098 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2015 | 707 | 0.020 |
Why?
|
| Publishing | 1 | 1997 | 836 | 0.020 |
Why?
|
| Water | 2 | 1994 | 1407 | 0.020 |
Why?
|
| Pituitary Hormones | 2 | 2006 | 182 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2006 | 4642 | 0.020 |
Why?
|
| Basement Membrane | 1 | 1991 | 348 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 1998 | 1056 | 0.020 |
Why?
|
| Cell Survival | 3 | 1987 | 5797 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 1999 | 2512 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 263 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2012 | 10344 | 0.020 |
Why?
|
| Decision Making | 2 | 2009 | 3925 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 16939 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 1999 | 1299 | 0.020 |
Why?
|
| Neurofibromatosis 1 | 2 | 1986 | 560 | 0.020 |
Why?
|
| Academies and Institutes | 1 | 1992 | 319 | 0.020 |
Why?
|
| Pituitary Hormones, Anterior | 2 | 1998 | 56 | 0.020 |
Why?
|
| Kinetics | 4 | 2011 | 6377 | 0.020 |
Why?
|
| Time | 1 | 2011 | 545 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2017 | 2913 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1998 | 2825 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1242 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 1992 | 412 | 0.020 |
Why?
|
| Hearing | 2 | 1984 | 501 | 0.020 |
Why?
|
| Staining and Labeling | 3 | 1994 | 1089 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 1189 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2022 | 4013 | 0.020 |
Why?
|
| Base Sequence | 3 | 2014 | 12446 | 0.020 |
Why?
|
| Monoamine Oxidase | 2 | 1986 | 178 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 2 | 1999 | 1913 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 1998 | 2417 | 0.020 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 1988 | 44 | 0.020 |
Why?
|
| beta Catenin | 1 | 2014 | 1043 | 0.020 |
Why?
|
| Diplopia | 1 | 2010 | 215 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2005 | 11481 | 0.020 |
Why?
|
| Brain Edema | 1 | 2012 | 603 | 0.020 |
Why?
|
| Image Enhancement | 1 | 1999 | 2881 | 0.020 |
Why?
|
| Cisterna Magna | 1 | 1987 | 39 | 0.020 |
Why?
|
| Clinical Trials as Topic | 4 | 2002 | 8056 | 0.020 |
Why?
|
| Mutation | 3 | 2017 | 29932 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 10827 | 0.020 |
Why?
|
| Hemangiosarcoma | 1 | 1990 | 216 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1994 | 2025 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 1988 | 412 | 0.020 |
Why?
|
| Cranial Nerve Injuries | 1 | 2007 | 28 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4107 | 0.020 |
Why?
|
| Pneumonia | 1 | 1999 | 2131 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2009 | 2262 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 1988 | 316 | 0.020 |
Why?
|
| Louisiana | 1 | 2007 | 104 | 0.020 |
Why?
|
| Fresh Water | 1 | 2007 | 82 | 0.020 |
Why?
|
| Nerve Compression Syndromes | 2 | 1986 | 160 | 0.020 |
Why?
|
| China | 1 | 1993 | 2339 | 0.020 |
Why?
|
| Cell Line | 4 | 1991 | 15620 | 0.020 |
Why?
|
| Scalp | 1 | 1970 | 389 | 0.020 |
Why?
|
| Empty Sella Syndrome | 2 | 1983 | 14 | 0.020 |
Why?
|
| Memory | 2 | 1988 | 2179 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2015 | 13451 | 0.020 |
Why?
|
| Nursing Methodology Research | 1 | 2006 | 64 | 0.020 |
Why?
|
| Medical Oncology | 1 | 1998 | 2313 | 0.020 |
Why?
|
| Neurofibrils | 1 | 1986 | 75 | 0.020 |
Why?
|
| Medulla Oblongata | 2 | 1985 | 248 | 0.020 |
Why?
|
| Peritoneum | 1 | 1987 | 224 | 0.020 |
Why?
|
| Blood Platelets | 3 | 1986 | 2520 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 1970 | 832 | 0.020 |
Why?
|
| Health Care Costs | 1 | 1999 | 3258 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2012 | 1017 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 2326 | 0.020 |
Why?
|
| Contrast Media | 1 | 1999 | 5305 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2003 | 4744 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 1994 | 1689 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 1997 | 3562 | 0.020 |
Why?
|
| Vestibular Function Tests | 2 | 1985 | 128 | 0.020 |
Why?
|
| Gonadotropins, Pituitary | 1 | 2005 | 69 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 1986 | 573 | 0.020 |
Why?
|
| Dysgerminoma | 1 | 1985 | 66 | 0.020 |
Why?
|
| Frontal Bone | 1 | 2005 | 105 | 0.020 |
Why?
|
| Disability Evaluation | 2 | 1999 | 1826 | 0.020 |
Why?
|
| Cerebellopontine Angle | 1 | 1985 | 53 | 0.020 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1985 | 144 | 0.020 |
Why?
|
| Endocrine System Diseases | 1 | 2007 | 250 | 0.020 |
Why?
|
| Torque | 1 | 2005 | 132 | 0.010 |
Why?
|
| Computational Biology | 1 | 2016 | 3505 | 0.010 |
Why?
|
| Meningitis | 2 | 1980 | 218 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2566 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 1986 | 447 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1987 | 863 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9411 | 0.010 |
Why?
|
| Caloric Tests | 1 | 1983 | 10 | 0.010 |
Why?
|
| Medical Errors | 1 | 2012 | 1255 | 0.010 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2009 | 611 | 0.010 |
Why?
|
| Pneumoencephalography | 1 | 1983 | 22 | 0.010 |
Why?
|
| Golgi Apparatus | 2 | 1988 | 404 | 0.010 |
Why?
|
| Ganglioneuroma | 1 | 1984 | 53 | 0.010 |
Why?
|
| Adenoma, Acidophil | 1 | 1983 | 2 | 0.010 |
Why?
|
| Muscle Spasticity | 1 | 2005 | 155 | 0.010 |
Why?
|
| S Phase | 1 | 2005 | 422 | 0.010 |
Why?
|
| Organometallic Compounds | 1 | 1987 | 662 | 0.010 |
Why?
|
| Facial Bones | 1 | 1985 | 205 | 0.010 |
Why?
|
| Hematoporphyrin Derivative | 1 | 1983 | 10 | 0.010 |
Why?
|
| Hospitals, Proprietary | 1 | 1983 | 39 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1998 | 3334 | 0.010 |
Why?
|
| Genome, Human | 1 | 2016 | 4417 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1970 | 1420 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1983 | 399 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 7021 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 2003 | 225 | 0.010 |
Why?
|
| Health Surveys | 2 | 1990 | 4063 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4713 | 0.010 |
Why?
|
| Hearing Loss, Conductive | 1 | 1983 | 159 | 0.010 |
Why?
|
| Facial Neoplasms | 1 | 1983 | 125 | 0.010 |
Why?
|
| Anorexia | 1 | 2003 | 154 | 0.010 |
Why?
|
| Audiometry, Evoked Response | 1 | 1981 | 45 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1988 | 3607 | 0.010 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 1982 | 134 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1994 | 2250 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1981 | 213 | 0.010 |
Why?
|
| Microcirculation | 1 | 1986 | 1278 | 0.010 |
Why?
|
| Methotrexate | 1 | 1988 | 1719 | 0.010 |
Why?
|
| Metyrapone | 1 | 1980 | 22 | 0.010 |
Why?
|
| Ethylnitrosourea | 1 | 1981 | 51 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2009 | 1784 | 0.010 |
Why?
|
| Arylsulfotransferase | 3 | 1985 | 28 | 0.010 |
Why?
|
| Orbital Neoplasms | 1 | 1983 | 221 | 0.010 |
Why?
|
| Visual Acuity | 2 | 1983 | 2643 | 0.010 |
Why?
|
| Gonads | 1 | 1981 | 109 | 0.010 |
Why?
|
| Pneumocephalus | 1 | 1981 | 47 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1993 | 9287 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2012 | 8313 | 0.010 |
Why?
|
| Developing Countries | 1 | 1993 | 2868 | 0.010 |
Why?
|
| Fistula | 1 | 1982 | 214 | 0.010 |
Why?
|
| Hospital Costs | 1 | 2007 | 976 | 0.010 |
Why?
|
| Light | 1 | 1986 | 1344 | 0.010 |
Why?
|
| Counseling | 1 | 1988 | 1548 | 0.010 |
Why?
|
| Cerebellar Cortex | 1 | 1981 | 107 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1988 | 1878 | 0.010 |
Why?
|
| Dianhydrogalactitol | 1 | 1979 | 3 | 0.010 |
Why?
|
| Nausea | 1 | 2003 | 678 | 0.010 |
Why?
|
| Sugar Alcohols | 1 | 1979 | 17 | 0.010 |
Why?
|
| Foramen Magnum | 1 | 1979 | 41 | 0.010 |
Why?
|
| Brain Stem | 1 | 1985 | 857 | 0.010 |
Why?
|
| Vomiting | 1 | 2003 | 650 | 0.010 |
Why?
|
| Vasopressins | 1 | 1980 | 355 | 0.010 |
Why?
|
| Receptors, Ghrelin | 1 | 1998 | 20 | 0.010 |
Why?
|
| Deep Brain Stimulation | 1 | 2007 | 820 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 1981 | 226 | 0.010 |
Why?
|
| Kyphosis | 1 | 1981 | 237 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5785 | 0.010 |
Why?
|
| Learning | 1 | 1988 | 1739 | 0.010 |
Why?
|
| Optic Nerve Diseases | 1 | 1982 | 342 | 0.010 |
Why?
|
| Radiotherapy, High-Energy | 2 | 1990 | 228 | 0.010 |
Why?
|
| Hypothalamic Hormones | 1 | 1979 | 145 | 0.010 |
Why?
|
| Paranasal Sinuses | 1 | 1981 | 265 | 0.010 |
Why?
|
| Propranolol | 1 | 1980 | 489 | 0.010 |
Why?
|
| Ear, Inner | 1 | 1982 | 424 | 0.010 |
Why?
|
| Tomography | 1 | 1980 | 411 | 0.010 |
Why?
|
| Hemostatic Techniques | 1 | 1979 | 114 | 0.010 |
Why?
|
| RNA Probes | 1 | 1998 | 111 | 0.010 |
Why?
|
| Angiography | 1 | 1983 | 1605 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4407 | 0.010 |
Why?
|
| Surgery, Plastic | 1 | 1985 | 643 | 0.010 |
Why?
|
| Life Tables | 1 | 1998 | 365 | 0.010 |
Why?
|
| Receptors, Somatostatin | 1 | 1998 | 136 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1983 | 1229 | 0.010 |
Why?
|
| Carcinoma, Basal Cell | 1 | 1983 | 559 | 0.010 |
Why?
|
| Sodium | 2 | 1995 | 1594 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1998 | 136 | 0.010 |
Why?
|
| Dopamine | 1 | 1984 | 1595 | 0.010 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 1983 | 781 | 0.010 |
Why?
|
| Lomustine | 1 | 1977 | 60 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1998 | 277 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1998 | 11712 | 0.010 |
Why?
|
| Optic Chiasm | 1 | 1977 | 91 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1986 | 1869 | 0.010 |
Why?
|
| Cyanides | 1 | 1977 | 83 | 0.010 |
Why?
|
| Receptor, IGF Type 1 | 1 | 1999 | 380 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 14660 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 1998 | 21025 | 0.010 |
Why?
|
| Activin Receptors | 1 | 1996 | 40 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 1999 | 749 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1993 | 9585 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6538 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2010 | 4373 | 0.010 |
Why?
|
| Emergencies | 1 | 1982 | 1211 | 0.010 |
Why?
|
| Diarrhea | 1 | 2003 | 1319 | 0.010 |
Why?
|
| Prednisone | 1 | 1980 | 1565 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1983 | 1501 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1983 | 2651 | 0.010 |
Why?
|
| Bone Diseases | 1 | 1979 | 419 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 1991 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 1986 | 2640 | 0.010 |
Why?
|
| Etoposide | 1 | 1977 | 630 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1977 | 384 | 0.010 |
Why?
|
| Inhibins | 1 | 1996 | 209 | 0.010 |
Why?
|
| Psychometrics | 1 | 1985 | 3051 | 0.010 |
Why?
|
| Luciferases | 1 | 1977 | 716 | 0.010 |
Why?
|
| Oxygen | 1 | 1986 | 4193 | 0.010 |
Why?
|
| Dogs | 1 | 1980 | 3841 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1977 | 796 | 0.010 |
Why?
|
| Follicle Stimulating Hormone, beta Subunit | 1 | 1994 | 58 | 0.010 |
Why?
|
| Activins | 1 | 1996 | 211 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 5870 | 0.010 |
Why?
|
| Pain, Intractable | 1 | 1975 | 132 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1995 | 325 | 0.010 |
Why?
|
| Transcription Factor Pit-1 | 1 | 1993 | 16 | 0.010 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1980 | 793 | 0.010 |
Why?
|
| Pressure | 1 | 1977 | 1156 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1993 | 12103 | 0.010 |
Why?
|
| Optic Nerve | 1 | 1977 | 567 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1998 | 2234 | 0.010 |
Why?
|
| Catheterization | 1 | 1979 | 1432 | 0.010 |
Why?
|
| 17-Ketosteroids | 1 | 1992 | 36 | 0.010 |
Why?
|
| Depression | 1 | 2013 | 8044 | 0.010 |
Why?
|
| Urea | 1 | 1995 | 446 | 0.010 |
Why?
|
| Dementia | 1 | 1987 | 2649 | 0.010 |
Why?
|
| NAD | 1 | 1977 | 609 | 0.010 |
Why?
|
| Mice | 2 | 2011 | 81208 | 0.010 |
Why?
|
| Models, Biological | 1 | 1989 | 9467 | 0.010 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 1992 | 99 | 0.010 |
Why?
|
| Exophthalmos | 2 | 1983 | 97 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 1992 | 199 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1993 | 313 | 0.010 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 1992 | 240 | 0.010 |
Why?
|
| Transplantation, Homologous | 2 | 1991 | 4810 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1977 | 1347 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 1 | 1992 | 257 | 0.010 |
Why?
|
| Age of Onset | 1 | 1998 | 3301 | 0.010 |
Why?
|
| Weight Loss | 1 | 2003 | 2686 | 0.010 |
Why?
|
| Microvilli | 1 | 1991 | 233 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 1978 | 1001 | 0.010 |
Why?
|
| Gels | 1 | 1992 | 419 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1992 | 869 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 1991 | 271 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1991 | 222 | 0.010 |
Why?
|
| Freeze Drying | 1 | 1970 | 101 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1988 | 6315 | 0.010 |
Why?
|
| Vestibulocochlear Nerve | 1 | 1970 | 115 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1998 | 4035 | 0.010 |
Why?
|
| Plasma Cells | 1 | 1994 | 591 | 0.010 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 1970 | 40 | 0.010 |
Why?
|
| Fertility | 1 | 1994 | 773 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1985 | 3204 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 4925 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2006 | 6465 | 0.010 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 1970 | 133 | 0.010 |
Why?
|
| Electric Stimulation Therapy | 1 | 1975 | 613 | 0.010 |
Why?
|
| Data Collection | 1 | 1998 | 3315 | 0.010 |
Why?
|
| Microtomy | 1 | 1969 | 44 | 0.010 |
Why?
|
| Menarche | 2 | 1983 | 529 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1988 | 18137 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1998 | 6360 | 0.000 |
Why?
|
| Endopeptidases | 1 | 1992 | 772 | 0.000 |
Why?
|
| Alzheimer Disease | 2 | 1987 | 8547 | 0.000 |
Why?
|
| Transforming Growth Factor beta | 1 | 1996 | 1959 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15840 | 0.000 |
Why?
|
| Probability | 1 | 1993 | 2475 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1969 | 412 | 0.000 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 1989 | 220 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1983 | 4024 | 0.000 |
Why?
|
| Electrodes | 1 | 1970 | 614 | 0.000 |
Why?
|
| Neurons | 2 | 1984 | 9426 | 0.000 |
Why?
|
| Dextrans | 1 | 1989 | 574 | 0.000 |
Why?
|
| Ependymoma | 1 | 1970 | 320 | 0.000 |
Why?
|
| Estradiol | 1 | 1994 | 1932 | 0.000 |
Why?
|
| Magnesium | 1 | 1970 | 810 | 0.000 |
Why?
|
| Selegiline | 1 | 1986 | 32 | 0.000 |
Why?
|
| Fibrosis | 1 | 1994 | 2042 | 0.000 |
Why?
|
| Potassium | 1 | 1970 | 1313 | 0.000 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1986 | 155 | 0.000 |
Why?
|
| Lysosomes | 1 | 1991 | 920 | 0.000 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1985 | 139 | 0.000 |
Why?
|
| Mitochondria | 2 | 1991 | 3600 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1969 | 865 | 0.000 |
Why?
|
| Diagnostic Imaging | 1 | 2000 | 3527 | 0.000 |
Why?
|
| Parathyroid Neoplasms | 1 | 1986 | 241 | 0.000 |
Why?
|
| Drug Stability | 1 | 1985 | 290 | 0.000 |
Why?
|
| Postmortem Changes | 1 | 1984 | 119 | 0.000 |
Why?
|
| Health Facilities | 1 | 1989 | 578 | 0.000 |
Why?
|
| Social Adjustment | 1 | 1986 | 632 | 0.000 |
Why?
|
| Immunochemistry | 1 | 1983 | 119 | 0.000 |
Why?
|
| Forehead | 1 | 1983 | 74 | 0.000 |
Why?
|
| Consciousness | 1 | 1989 | 602 | 0.000 |
Why?
|
| Thermodynamics | 1 | 1984 | 599 | 0.000 |
Why?
|
| Corpus Callosum | 1 | 1987 | 749 | 0.000 |
Why?
|
| Catechol O-Methyltransferase | 1 | 1984 | 251 | 0.000 |
Why?
|
| Endoplasmic Reticulum | 1 | 1988 | 1132 | 0.000 |
Why?
|
| Patient Discharge | 1 | 1995 | 3476 | 0.000 |
Why?
|
| Blepharoptosis | 1 | 1983 | 143 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1991 | 3682 | 0.000 |
Why?
|
| Biological Assay | 1 | 1985 | 630 | 0.000 |
Why?
|
| Maxilla | 1 | 1985 | 491 | 0.000 |
Why?
|
| Tongue | 1 | 1985 | 404 | 0.000 |
Why?
|
| Dietary Carbohydrates | 1 | 1986 | 892 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1986 | 2502 | 0.000 |
Why?
|
| Intelligence | 1 | 1986 | 921 | 0.000 |
Why?
|
| Intracranial Pressure | 1 | 1982 | 325 | 0.000 |
Why?
|
| Pulse | 1 | 1980 | 218 | 0.000 |
Why?
|
| Mandible | 1 | 1985 | 750 | 0.000 |
Why?
|
| Bone Transplantation | 1 | 1985 | 922 | 0.000 |
Why?
|
| Osteotomy | 1 | 1985 | 836 | 0.000 |
Why?
|
| Leukopenia | 1 | 1979 | 211 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1985 | 1435 | 0.000 |
Why?
|
| Preanesthetic Medication | 1 | 1978 | 48 | 0.000 |
Why?
|
| Seasons | 1 | 1984 | 1522 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1991 | 5961 | 0.000 |
Why?
|
| Renin | 1 | 1980 | 635 | 0.000 |
Why?
|
| Morbidity | 1 | 1983 | 1765 | 0.000 |
Why?
|
| Hearing Loss | 1 | 1984 | 780 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1992 | 18957 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1983 | 1273 | 0.000 |
Why?
|
| Electric Stimulation | 1 | 1981 | 1735 | 0.000 |
Why?
|
| Nasal Polyps | 1 | 1981 | 395 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1984 | 2415 | 0.000 |
Why?
|
| Spine | 1 | 1981 | 1111 | 0.000 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1980 | 1259 | 0.000 |
Why?
|
| Radiographic Image Enhancement | 1 | 1977 | 875 | 0.000 |
Why?
|
| Spinal Fusion | 1 | 1981 | 1281 | 0.000 |
Why?
|
| Anticonvulsants | 1 | 1980 | 1879 | 0.000 |
Why?
|
| Ischemic Attack, Transient | 1 | 1976 | 901 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1980 | 8525 | 0.000 |
Why?
|
| Aging | 1 | 1980 | 8651 | 0.000 |
Why?
|